Skip to content
BHP

MHRA

UK Medicines and Healthcare products Regulatory Agency — licenses medicines for UK use.

For laboratory and research use only — not for human consumption.

The MHRA is the UK regulator responsible for assessing and licensing medicines, medical devices, and blood components. A research peptide that is not MHRA-licensed for any indication cannot be marketed, supplied, or administered as a medicine in the UK. None of the peptides profiled on this site holds current MHRA marketing authorisation as a healing or regeneration therapeutic. Possession for in-vitro and pre-clinical laboratory research is unrestricted; supply for human use is subject to the Human Medicines Regulations 2012 and may constitute a criminal offence.

Related glossary terms